London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.

The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest.

During a live event, Matthew Galsky, MD, discussed adjuvant and neoadjuvant treatment approaches for muscle-invasive bladder ...

Donegal High School held its commencement June 5. The graduates are: Ayomikun Rehoboth Akinrinwoye, Maria Gabriela Aleman ...

England becomes the first country to offer the world’s pioneering 'Trojan horse' blood cancer drug, through NHS, promising ...

Patients with eosinophilic granulomatosis with polyangiitis experienced significant improvements in a variety of outcomes ...

THOU DOTH PORTEST — Protests are set to pop up around the Bay State this weekend, capping off a week of tension between the ...